Judith Lind

703 total citations
17 papers, 559 citations indexed

About

Judith Lind is a scholar working on Surgery, Molecular Biology and Hematology. According to data from OpenAlex, Judith Lind has authored 17 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Molecular Biology and 6 papers in Hematology. Recurrent topics in Judith Lind's work include Helicobacter pylori-related gastroenterology studies (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Galectins and Cancer Biology (4 papers). Judith Lind is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Galectins and Cancer Biology (4 papers). Judith Lind collaborates with scholars based in Austria, Germany and United States. Judith Lind's co-authors include Steffen Backert, Nicole Tegtmeyer, Suneesh Kumar Pachathundikandi, Anne Müller, Heinrich Sticht, Emad El‐Omar, Mara L. Hartung, Andreas Kyburz, Christian Taube and Sabine Urban and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Judith Lind

17 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith Lind Austria 11 334 276 141 81 77 17 559
Philipp Schlaermann Germany 6 246 0.7× 175 0.6× 172 1.2× 25 0.3× 115 1.5× 7 517
Garrett Z. Ng Australia 17 244 0.7× 265 1.0× 180 1.3× 49 0.6× 67 0.9× 32 571
Yeganeh Talebkhan Iran 13 295 0.9× 215 0.8× 118 0.8× 61 0.8× 55 0.7× 40 523
Jonathan Ferrand Australia 14 246 0.7× 286 1.0× 222 1.6× 39 0.5× 123 1.6× 23 675
Guangxian Xu China 11 126 0.4× 321 1.2× 299 2.1× 28 0.3× 224 2.9× 33 689
Aki Imai‐Matsushima Germany 8 159 0.5× 188 0.7× 143 1.0× 19 0.2× 66 0.9× 8 456
Ali A. Akhiani Sweden 12 327 1.0× 406 1.5× 91 0.6× 103 1.3× 63 0.8× 17 592
B. Samuel Lundin Sweden 10 241 0.7× 337 1.2× 78 0.6× 27 0.3× 56 0.7× 12 520
Liviu A. Sicinschi United States 15 770 2.3× 421 1.5× 186 1.3× 105 1.3× 99 1.3× 22 1.0k
Dominic De Groote Belgium 8 262 0.8× 48 0.2× 92 0.7× 145 1.8× 70 0.9× 10 424

Countries citing papers authored by Judith Lind

Since Specialization
Citations

This map shows the geographic impact of Judith Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Lind more than expected).

Fields of papers citing papers by Judith Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Lind. The network helps show where Judith Lind may publish in the future.

Co-authorship network of co-authors of Judith Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Lind. A scholar is included among the top collaborators of Judith Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Lind. Judith Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lind, Judith, Michaela Prchal‐Murphy, Fengjuan Fan, et al.. (2024). Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity. Blood Cancer Journal. 14(1). 138–138. 3 indexed citations
2.
Lind, Judith, Roland Hellinger, Herwig P. Moll, et al.. (2022). The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma. Biomedicine & Pharmacotherapy. 153. 113486–113486. 3 indexed citations
3.
Lind, Judith, et al.. (2022). Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications. Cytokine. 161. 156062–156062. 6 indexed citations
4.
Lind, Judith, et al.. (2022). On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future. Expert Opinion on Pharmacotherapy. 23(12). 1425–1444. 2 indexed citations
5.
Lind, Judith, Sonia Vallet, Karoline Kollmann, et al.. (2021). Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs Inducing Synergistic Anti-Myeloma Activity. Blood. 138(Supplement 1). 2644–2644. 1 indexed citations
6.
Lind, Judith, et al.. (2021). P-082: Delineating CDK9- regulated molecular events for the development of rationally derived multiple myeloma treatment strategies. Clinical Lymphoma Myeloma & Leukemia. 21. S83–S84. 1 indexed citations
7.
Tegtmeyer, Nicole, Matthias Neddermann, Judith Lind, et al.. (2020). Toll-like Receptor 5 Activation by the CagY Repeat Domains of Helicobacter pylori. Cell Reports. 32(11). 108159–108159. 42 indexed citations
8.
Pachathundikandi, Suneesh Kumar, Nicole Tegtmeyer, Isabelle C. Arnold, et al.. (2019). T4SS-dependent TLR5 activation by Helicobacter pylori infection. Nature Communications. 10(1). 5717–5717. 61 indexed citations
9.
Lind, Judith, et al.. (2019). Emerging protein kinase inhibitors for the treatment of multiple myeloma. Expert Opinion on Emerging Drugs. 24(3). 133–152. 22 indexed citations
10.
Lind, Judith, Steffen Backert, Jutta Eichler, et al.. (2016). Systematic analysis of phosphotyrosine antibodies recognizing single phosphorylated EPIYA-motifs in CagA of East Asian-type Helicobacter pylori strains. BMC Microbiology. 16(1). 201–201. 30 indexed citations
11.
Boehm, Manja, Judith Lind, Steffen Backert, & Nicole Tegtmeyer. (2015). Campylobacter jejuniserine protease HtrA plays an important role in heat tolerance, oxygen resistance, host cell adhesion, invasion, and transmigration. European Journal of Microbiology and Immunology. 5(1). 68–80. 51 indexed citations
12.
Pachathundikandi, Suneesh Kumar, Judith Lind, Nicole Tegtmeyer, Emad El‐Omar, & Steffen Backert. (2015). Interplay of the Gastric PathogenHelicobacter pyloriwith Toll-Like Receptors. BioMed Research International. 2015. 1–12. 70 indexed citations
13.
Hartung, Mara L., Sabine Urban, Andreas Kyburz, et al.. (2015). Helicobacter urease–induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. Journal of Clinical Investigation. 125(8). 3297–3302. 120 indexed citations
14.
Tenguria, Shivendra, Suhail A. Ansari, Nooruddin Khan, et al.. (2014). Helicobacter pylori cell translocating kinase (CtkA/JHP0940) is pro-apoptotic in mouse macrophages and acts as auto-phosphorylating tyrosine kinase. International Journal of Medical Microbiology. 304(8). 1066–1076. 23 indexed citations
15.
Tegtmeyer, Nicole, Judith Lind, Benedikt Schmid, & Steffen Backert. (2014). Helicobacter pylori CagL Y58/E59 Mutation Turns-Off Type IV Secretion-Dependent Delivery of CagA into Host Cells. PLoS ONE. 9(6). e97782–e97782. 25 indexed citations
16.
Lind, Judith, Steffen Backert, Douglas E. Berg, et al.. (2014). Systematic Analysis of Phosphotyrosine Antibodies Recognizing Single Phosphorylated EPIYA-Motifs in CagA of Western-Type Helicobacter pylori Strains. PLoS ONE. 9(5). e96488–e96488. 30 indexed citations
17.
Lind, Judith, et al.. (2010). Enrichment of circulating tumor cells from a large blood volume using leukapheresis and elutriation: Proof of concept. Cytometry Part B Clinical Cytometry. 80B(2). 100–111. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philipp Schlaermann Breakdown of academic impact, for papers by Garrett Z. Ng Breakdown of academic impact, for papers by Yeganeh Talebkhan Breakdown of academic impact, for papers by Jonathan Ferrand Breakdown of academic impact, for papers by Guangxian Xu Breakdown of academic impact, for papers by Aki Imai‐Matsushima Breakdown of academic impact, for papers by Ali A. Akhiani Breakdown of academic impact, for papers by B. Samuel Lundin Breakdown of academic impact, for papers by Liviu A. Sicinschi Breakdown of academic impact, for papers by Dominic De Groote
Rankless by CCL
2026